Imagen de Portada

Safety-Driven Response Adaptive Randomisation: An Application in Non-inferiority Oncology Trials

Fuente: arXiv

Guardado en:

Detalles Bibliográficos
Autores principales:	Chiaruttini, Maria Vittoria, Pin, Lukas, Villar, Sofia S.
Formato:	Preprint
Publicado:	2025
Materias:	Methodology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
por: Maria Vittoria Chiaruttini, et al.
Publicado: (2026)

Implementing Response-Adaptive Randomisation in Stratified Rare-disease Trials: Design Challenges and Practical Solutions
por: Das, Rajenki, et al.
Publicado: (2024)

Is 1:1 Always Most Powerful? Why Careful Determination of Allocation Ratios Matters in Trial Design
por: Pin, Lukas, et al.
Publicado: (2025)

Revisiting Optimal Allocations for Binary Responses: Insights from Considering Type-I Error Rate Control
por: Pin, Lukas, et al.
Publicado: (2025)

Informed Burn-In Decisions in RAR: Harmonizing Adaptivity and Inferential Precision Based on Study Setting
por: Pin, Lukas, et al.
Publicado: (2025)

A computational method for type I error rate control in power-maximizing response-adaptive randomization
por: Baas, Stef, et al.
Publicado: (2025)

Two-stage Adaptive Design Cluster Randomised Trials
por: Watson, Samuel I., et al.
Publicado: (2026)

A burn-in(g) question: How long should an initial equal randomization stage be before Bayesian response-adaptive randomization?
por: Tang, Edwin Y. N., et al.
Publicado: (2025)

Thompson, Ulam, or Gauss? Multi-criteria recommendations for posterior probability computation methods in Bayesian response-adaptive trials
por: Kaddaj, Daniel, et al.
Publicado: (2024)

Exact statistical analysis for response-adaptive clinical trials: A general and computationally tractable approach
por: Baas, Stef, et al.
Publicado: (2024)

TITE-Safety: Time-to-event Safety Monitoring for Clinical Trials
por: Martens, Michael J., et al.
Publicado: (2025)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
por: Komaki, Moka, et al.
Publicado: (2025)

A Dual Cox Model Theory And Its Applications In Oncology
por: Chen, Powei, et al.
Publicado: (2023)

Estimands for Early Phase Dose Optimization Trials in Oncology
por: Mukherjee, Ayon, et al.
Publicado: (2025)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
por: Lee, Kyong Ju, et al.
Publicado: (2025)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
por: Chen, Yuxuan, et al.
Publicado: (2026)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
por: Sunami, Hisato, et al.
Publicado: (2024)

Analysis of Stepped-Wedge Randomised Cluster Trial using a generalized pairwise comparison approach : a simulation study
por: Bard, Yohan, et al.
Publicado: (2026)

An integer programming-based approach to construct exact two-sample binomial tests with maximum power
por: Baas, Stef, et al.
Publicado: (2025)

Operationalizing Allocation Probability Tests: Practical Guidance on Optimized Implementation for Power and Robustness
por: Zetterstrom, Stina, et al.
Publicado: (2026)

Building a Standardised Statistical Reporting Toolbox in an Academic Oncology Clinical Trials Unit: The grstat R Package
por: Chaltiel, Dan, et al.
Publicado: (2026)

Randomization-based Inference for MCP-Mod
por: Pin, Lukas, et al.
Publicado: (2024)

Outlier Detection in Mendelian Randomisation
por: Mandl, Maximilian M, et al.
Publicado: (2025)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
por: Hall, Andrew, et al.
Publicado: (2025)

Stratification in Randomised Clinical Trials for Rare Diseases and Analysis of Covariance: Some Simple Theory and Recommendations
por: Senn, Stephen, et al.
Publicado: (2024)

Externally Valid Policy Evaluation Combining Trial and Observational Data
por: Ek, Sofia, et al.
Publicado: (2023)

Nonparametric Bayesian Multi-Treatment Mixture Cure Survival Model with Application in Pediatric Oncology
por: Chang, Peter, et al.
Publicado: (2025)

Cumulative Logit Ordinal Regression with Proportional Odds under Nonignorable Missing Response -- Application to Phase III Trial
por: Maity, Arnab Kumar, et al.
Publicado: (2025)

Data-Driven Adjustment for Multiple Treatments
por: LaPlante, Sara, et al.
Publicado: (2025)

Estimands for Randomized Discontinuation Designs in Oncology
por: Mukherjee, Ayon, et al.
Publicado: (2025)

Causal Survival Analysis in Platform Trials with Non-Concurrent Controls
por: D'Alessandro, Antonio, et al.
Publicado: (2026)

Likelihood-based Inference for Skewed Responses in a Crossover Trial Setup
por: Pareek, Savita, et al.
Publicado: (2023)

Validation and Comparison of Non-Stationary Cognitive Models: A Diffusion Model Application
por: Schumacher, Lukas, et al.
Publicado: (2023)

Principles of Conditionality and Layering of Error Rates with Application to Platform Trials
por: Cui, Xinping, et al.
Publicado: (2023)

Model-robust Inference for Seamless II/III Trials with Covariate Adaptive Randomization
por: Yi, Kun, et al.
Publicado: (2025)

Improving Treatment Effect Estimation in Trials through Adaptive Borrowing of External Controls
por: Yang, Qinwei, et al.
Publicado: (2026)

An Adaptive Phase II Trial Design for Dose Selection and Addition in Microfilarial Infections
por: Zehetmayer, Sonja, et al.
Publicado: (2026)

Component over Composite: Mitigating Type I Error Inflation when Imputing "Days Alive and at Home"
por: Tackney, Mia S., et al.
Publicado: (2026)

A Non-Parametric Sensitivity Analysis for Bounding Bias in Hybrid Control Trials
por: Gordon, Alissa, et al.
Publicado: (2025)

Markov-Restricted Analysis of Randomized Trials with Non-Monotone Missing Binary Outcomes
por: Lee, Jaron J. R., et al.
Publicado: (2021)